Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Riesenberg · SciRah

Researcher profile · Semantic Scholar

R. Riesenberg

Share profile

R. Riesenberg — researcher profile on SciRah

h-index: 19
Works: 42
Citations: 2,351

Most-cited papers

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.
S. Meltzer-Brody, H. Colquhoun, R. Riesenberg, C. Epperson +8 more
2018The Lancet487 citations
Semantic Scholar
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
S. Kanes, H. Colquhoun, H. Gunduz-Bruce, S. Raines +11 more
2017The Lancet363 citations
Semantic Scholar
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
L. Dunkle, K. Kotloff, C. Gay, G. Áñez +29 more
2021medRxiv331 citations Open access
Semantic Scholar
Trial of SAGE-217 in Patients with Major Depressive Disorder.
H. Gunduz-Bruce, C. Silber, I. Kaul, A. Rothschild +10 more
2019New England Journal of Medicine187 citations Open access
Semantic Scholar
Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine
M. Lesem, T. Tran-Johnson, R. Riesenberg, D. Feifel +5 more
2011British Journal of Psychiatry151 citations Open access
Semantic Scholar
Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo‐controlled clinical trial with inhaled loxapine
J. Kwentus, R. Riesenberg, M. Marandi, Raymond A. Manning +5 more
2012Bipolar Disorders118 citations
Semantic Scholar
Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study.
J. Mendels, R. Johnston, J. Mattes, R. Riesenberg
1993Psychopharmacology bulletin85 citations
Semantic Scholar
Liraglutide effects in a paediatric (7‐11 y) population with obesity: A randomized, double‐blind, placebo‐controlled, short‐term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics
L. Mastrandrea, L. Witten, Kristin C. Carlsson Petri, P. M. Hale +2 more
2019Pediatric obesity84 citations Open access
Semantic Scholar
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age
F. Muñoz, L. Sher, Charu Sabharwal, A. Gurtman +34 more
2023New England Journal of Medicine73 citations Open access
Semantic Scholar
Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program.
C. Epperson, D. Rubinow, S. Meltzer-Brody, K. Deligiannidis +8 more
2022Journal of Affective Disorders70 citations Open access
Semantic Scholar
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial
K. Hardt, A. Vandebosch, J. Sadoff, Mathieu le Gars +284 more
2022Lancet. Infectious Diseases (Print)65 citations Open access
Semantic Scholar
Effect of Raltegravir on the Pharmacokinetics of Methadone
Matt S. Anderson, J. Luk, W. Hanley, B. Jin +5 more
2010Journal of clinical pharmacology47 citations
Semantic Scholar
PF-06649751 efficacy and safety in early Parkinson’s disease: a randomized, placebo-controlled trial
R. Riesenberg, J. Werth, Yao Zhang, S. Duvvuri +1 more
2020Therapeutic Advances in Neurological Disorders45 citations Open access
Semantic Scholar
Effectiveness and Safety of Velnacrine for the Treatment of Alzheimer's Disease: A Double-blind, Placebo-Controlled Study
P. Antuono, J. Ravanelli-Meyer, J. Beyer, W. A. Brown +37 more
199544 citations
Semantic Scholar
Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
David A. Brown, K. Nakagome, J. Cordes, R. Brenner +8 more
2017Schizophrenia bulletin40 citations Open access
Semantic Scholar
A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjects.
M. Mitchell, R. Riesenberg, M. A. Bari, E. Marquez +6 more
2006Clinical Therapeutics31 citations
Semantic Scholar
Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
R. Riesenberg, Irina Baldytcheva, C. Datto
2012Clinical Therapeutics22 citations
Semantic Scholar
Brexanolone Injection in Postpartum Depression: 2 Multicenter, Double-blind, Randomized, Placebo-controlled Phase 3 Trials
S. Meltzer-Brody, H. Colquhoun, R. Riesenberg, C. Epperson +8 more
2019Obstetric Anesthesia Digest20 citations
Semantic Scholar
Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens
D. Spyker, R. Riesenberg, J. Cassella
2015Journal of clinical pharmacology20 citations Open access
Semantic Scholar
Pharmacokinetics and Safety of Single‐Dose Inhaled Loxapine in Children and Adolescents
S. Selim, R. Riesenberg, J. Cassella, J. Kunta +4 more
2017Journal of clinical pharmacology11 citations
Semantic Scholar
Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache
D. Kudrow, J. Andrews, M. Rettiganti, T. Oakes +6 more
2020Headache9 citations Open access
Semantic Scholar
P.2.152 Ziprasidone in mania: A 21-day randomized, double-blind, placebo controlled trial
S. Segal, R. Riesenberg, Kathleen Ice, P. English
20038 citations
Semantic Scholar
T136. Safety and Efficacy of Intravenous Ganaxolone in Severe Postpartum Depression: Results From a Double-Blind, Placebo-Controlled Phase 2 Study
R. Gutierrez-esteinou, B. Maximos, R. Riesenberg, K. A. Johnson +3 more
2019Biological Psychiatry6 citations
Semantic Scholar
Asenapine pharmacokinetics and tolerability in a pediatric population
P. Dogterom, R. Riesenberg, R. de Greef, J. Dennie +7 more
2018Drug Design, Development and Therapy6 citations Open access
Semantic Scholar
SAGE-217 in major depressive disorder: A multicenter, randomized, double-blind, Phase 2 placebo-controlled trial
H. Gunduz-Bruce, Christopher Silber, A. Rothschild, R. Riesenberg +9 more
2019European Neuropsychopharmacology5 citations
Semantic Scholar
S100. Efficacy and Safety of Brexanolone IV Across Phase 2/3 Studies: A First-In-Class GABAA Receptor Positive Allosteric Modulator for Postpartum Depression
S. Meltzer-Brody, S. Kanes, R. Riesenberg, C. Epperson +5 more
20184 citations
Semantic Scholar
Brexanolone in Adolescent Patients with Postpartum Depression: Results from the Phase 3, Open-Label CHICKADEE Study
R. Riesenberg, Kemi Bankole, Svetlana Garafola, M. Qin +4 more
2022American Journal of Obstetrics and Gynecology3 citations Open access
Semantic Scholar
ITI-214, A Novel Phosphodiesterase I Inhibitor for the Treatment of Parkinson’s Disease: Results from A Phase I/II Clinical Study (P2.8-051)
Robert Davis, R. Riesenberg, D. Laskowitz, J. Guptill +17 more
2019Neurology3 citations
Semantic Scholar
Sedation intensity during dose escalation of quetiapine XR or IR in bipolar depression: a multicenter, double-blind, randomized, phase IV study
R. Riesenberg, C. Datto, Irina Baldytcheva
20113 citations
Semantic Scholar
Brexanolone iv efficacy in postpartum depression in three pivotal trials: montgomery‐åsberg depression rating scale assessment: 86
C. Clemson, S. Meltzer-Brody, H. Colquhoun, R. Riesenberg +5 more
2019American Journal of Obstetrics and Gynecology2 citations Open access
Semantic Scholar
SAGE-217 in subjects with major depressive disorder: efficacy and safety results from open-label Part A of a phase 2A study
H. Gunduz-Bruce, R. Riesenberg, A. Sankoh, H. Li +6 more
20172 citations
Semantic Scholar
Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder
R. Riesenberg, J. Rosenthal, Leslie Moldauer, C. Peterson
2011Psychopharmacology2 citations
Semantic Scholar
P.2.081 A preliminary study of the pharmacokinetics and tolerability of higher dose oral olanzapine (20, 30, or 40mg/day) in stable patients with serious mental disorders
M. Mitchell, W. Earley, M. A. Bari, R. Riesenberg +5 more
20032 citations
Semantic Scholar
Reduction in Depressive Symptoms Over the First 24 Hours in Patients With PPD Treated With the Neuroactive Steroid Brexanolone Injection
S. Meltzer-Brody, R. Riesenberg, C. Epperson, K. Deligiannidis +5 more
2020Biological Psychiatry1 citations
Semantic Scholar
Health-related quality of life in a Phase 2, randomized, placebo-controlled trial of the GABA(A)R modulator SAGE-217 in major depressive disorder
V. Bonthapally, H. Gunduz-Bruce, Christopher Silber, A. Rothschild +11 more
2019European Neuropsychopharmacology1 citations
Semantic Scholar
Brexanolone iv, a GABA-A receptor modulator, in postpartum depression: Pooled analysis of HAM-D sub-items
S. Meltzer-Brody, H. Colquhoun, R. Riesenberg, C. Epperson +5 more
2019European Neuropsychopharmacology1 citations
Semantic Scholar
2.45 A Phase 4, Open-Label, Multicenter, Single-Dose Study of the Pharmacokinetics of a Novel Amphetamine Extended-Release Oral Disintegrating Tablet Formulation (Adzenys XR-ODT™) in Preschool-Aged Children
R. Riesenberg, Andrea Marraffino, Dorothy Engelking, T. Laage +3 more
2018Journal of the American Academy of Child and Adolescent Psychiatry1 citations
Semantic Scholar
Effect of BI 409306 on Positive and Negative Syndrome Scale in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
M. Sand, K. Nakagome, J. Cordes, R. Brenner +8 more
20181 citations
Semantic Scholar
Phase 3 Study Evaluating Brexanolone, a GABAA Receptor Modulator, in Moderate Postpartum Depression [25H]
S. Kanes, H. Colquhoun, R. Riesenberg, D. Rubinow +2 more
20181 citations
Semantic Scholar
O46. SAGE-217 a First in Class GABAA Receptor Positive Allosteric Modulator in Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Phase 2 Placebo-Controlled Trial
H. Gunduz-Bruce, C. Silber, A. Rothschild, R. Riesenberg +9 more
20181 citations
Semantic Scholar
P.309 Double-blind, randomized, placebo-controlled trials of brexanolone injection in postpartum depression: analysis of ham-d depression subscales and individual symptom items
S. Meltzer-Brody, H. Colquhoun, R. Riesenberg, C. Epperson +6 more
2019European Neuropsychopharmacology0 citations
Semantic Scholar
F73. Efficacy of Brexanolone Injection in Subjects With Postpartum Depression With and Without Baseline Antidepressant Therapy: Insights From an Integrated Analysis of Three Pivotal Trials
S. Meltzer-Brody, H. Colquhoun, R. Riesenberg, N. Epperson +5 more
2019Biological Psychiatry0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Kanes×17
Invite
S. Kanes — researcher profile on SciRah
D. Rubinow×12
Invite
D. Rubinow — researcher profile on SciRah
S. Meltzer-Brody×11
Invite
S. Meltzer-Brody — researcher profile on SciRah
K. Deligiannidis×10
Invite
K. Deligiannidis — researcher profile on SciRah

×10

Invite

Hai-Hong Li — researcher profile on SciRah

H. Colquhoun×9

Invite

H. Colquhoun — researcher profile on SciRah

Invite

C. Epperson — researcher profile on SciRah

Invite

A. Sankoh — researcher profile on SciRah

Invite

J. Jonas — researcher profile on SciRah

Invite

C. Clemson — researcher profile on SciRah

H. Gunduz-Bruce×6

Invite

H. Gunduz-Bruce — researcher profile on SciRah

Invite

J. Doherty — researcher profile on SciRah